NCT05977803Recruiting
Contribution of the CEST Sequence in the Characterization of Radionecrosis of Brain Metastases of Pulmonary Origin
Source: ClinicalTrials.gov · Last updated 31 Mar 2026
Brief summary (registry, in English)
The aim of the study is to determine whether the use of the CEST sequence would have diagnostic performance equivalent to the reference method of T2\* infusion with contrast injection in the diagnosis of radionecrosis of lung cancer brain metastases.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 21 Jun 2023
- Start date
- Feb 2024
- Primary completion date
- Feb 2029
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- NCT number
- NCT05977803
What you commit to
- Study type: Interventional
- Planned participants: 60
- From Feb 2024 to the primary completion date, Feb 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cognitive impairment making informed consent impossible
Other
- Opposition to the study
- Contraindication to MRI
- Refusal of imaging by the patient
- Patient with state medical aid (unless exemption from affiliation)
- Patients under guardianship or deprived of liberty
Who the study is looking for
- Patients \> 18 years of age
- Histologically proven primary lung cancer
- Histologically proven or not brain metastases
- Irradiated metastases
- Inclusion in a treatment protocol for brain metastases by brain metastasis in toto or stereotactic or gamma-knife radiotherapy
- Morphological increase of one or more lesions of secondary brain metastases on a follow-up MRI
- Patients affiliated to a social security scheme
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hôpital Bichat - Claude-Bernard Coordinator of this site? Confirm its status | Paris | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.